Associated Papers
[Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 2007
Evaluation of therapy of X-linked adrenoleukodystrophy.
Moser HW et al.
Neurochemical Research, 2004
Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice.
Cartier N et al.
Febs Letters, 2000
X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?
Aubourg P et al.
Glia, 2000
Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
Yamada T et al.
Cell Biochemistry and Biophysics, 2000
A mouse model for X-linked adrenoleukodystrophy.
Lu JF et al.
Proceedings of the National Academy of Sciences of the United States of America, 1997
[Adrenoleukodystrophy: significance for genetic counseling of the determination of very long-chain fatty acids and of molecular biology].
Mathieu M et al.
Annales De Pediatrie, 1990
Select a paper to view details